A major fund for biodiversity remains starved of resources more than five months after its launch – with no money yet put ...

Click here to view the custom infographic of the Soligenix Inc. editorial. Clickhere  to view the custom infographic of the ...

Soligenix's HyBryte (synthetic hypericin) offers a promising solution as a potential first-line therapy for early-stage CTCL. By addressing this critical gap in care, HyBryte has the potential to ...

As the American population gets older, chronic and rare diseases are becoming a significant healthcare issue, particularly ...

Chronic rare diseases are becoming a major challenge for the aging population in the United States. As life expectancy rises, healthcare needs become more complex, especially for conditions that are ...